Concepedia

Publication | Open Access

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer

DOIFull Paper Access

25

Citations

31

References

2022

Year

M.A. Bergamino, Elena López‐Knowles, Gabriele Morani, Holly Tovey, Lucy Kilburn, Eugene F. Schuster, Anastasia Alataki, Margaret Hills, Hui Xiao, Chris Holcombe,
EBioMedicine

Abstract

Cancer Research UK (CRUK/07/015).

References

YearCitations

Page 1